Related references
Note: Only part of the references are listed.Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression
David M. Frazer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT
Sandra L. Ross et al.
CELL METABOLISM (2012)
Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia
Khaled M. Musallam et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
Ayalew Tefferi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
Damien R. Ashby et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
The Role of Hepcidin in Iron Metabolism
Elizabeta Nemeth et al.
ACTA HAEMATOLOGICA (2009)
Hepcidin compared with prohepcidin: an absorbing story
David M. Frazer et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Decreased serum prohepcidin concentration in patients with polycythemia vera
Justyna Kwapisz et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2009)
Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2
Ivana De Domenico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines
Oliver Bock et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I
Hannah Tamary et al.
BLOOD (2008)
Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis
Asher Winder et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Serum hepcidin level and erythropoietic activity after hematopoletic stem cell transplantation
Junya Kanda et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors
Alan E. Mast et al.
TRANSFUSION (2008)
The Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism
M. D. Fleming
Hematology-American Society of Hematology Education Program (2008)
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Toshihiko Tanno et al.
NATURE MEDICINE (2007)
JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients
L. Florensa et al.
LEUKEMIA (2006)
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6
Jaroslav Truksa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
JB Welsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
